Introduction Executive Summary Psoriatic arthritis: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Psoriatic arthritis – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Psoriatic arthritis companies’ collaborations, Licensing, Acquisition -Deal Value Trends Psoriatic arthritis Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Preregistration) • Comparative Analysis Tildrakizumab: Sun Pharma Global • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis BMS-986165: Bristol-Myers Squibb • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Apremilast: 3SBio • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery stage Products • Comparative Analysis ALPN 101: Alpine Immune Sciences • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Psoriatic arthritis Key Companies Psoriatic arthritis Key Products Psoriatic arthritis- Unmet Needs Psoriatic arthritis- Market Drivers and Barriers Psoriatic arthritis- Future Perspectives and Conclusion Psoriatic arthritis Analyst Views Psoriatic arthritis Key Companies Appendix

Table 1 Total Products for Psoriatic arthritis Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Sun Pharma Global • UCB Biopharma • Pfizer • Bristol-Myers Squibb • AbGenomics • Boehringer Ingelheim • Affibody • AltruBio • Synact Pharma • NeuClone • 3SBio • Qyuns Therapeutics • Kangpu Biopharmaceuticals • Alpine Immune Sciences • Avotres • Xbrane Biopharma • XBiotech • Evelo • Luye Pharma Group • Levolta Pharmaceuticals • DNX Biopharmaceuticals • Mycenax Biotech